Paola Queirolo, Dr.
Ospedale Policlinico San Martino di Genova
1
1
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Peter Lau, MBBS
Harry Perkins Institute for Medical Research
Shared therapeutic areas:
Kristina Orlova, MD, PhD
Association Professional Melanoma Society (MELANOMA.PRO)
Shared therapeutic areas:
Petr Arenberger
Fakultni Nemocnice Kralovske Vinohrady, Czech Republic
Shared therapeutic areas:
Jean-Bernard AULIAC, Dr
Créteil -CHI
Shared therapeutic areas:
Philippe Saiag, Prof
APHP - CHU Ambroise Paré
Shared therapeutic areas:
Peter Mohr, MD
Department of Dermatology, Elbe Kliniken, Buxtehude, Germany
Shared therapeutic areas:
François Denjean
Pierre Fabre Médicament
Shared therapeutic areas:
Zeynep Eroglu, MD
Moffitt Cancer Center
Shared therapeutic areas:
Nicolas Meyer, MD, PhD
Head of Skin Cancer Unit, Toulouse University Cancer Institute, CHU Larrey et Oncopôle, France
Shared therapeutic areas:
Angela Hong
Melanoma Institute Australia
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
To Evaluate the Efficacy Beyond Progression of Vemurafenib+Cobimetinib Associated With Local Treatment Compared to Second-line Treatment in Patients With BRAFV600+ Metastatic Melanoma in Focal Progression With First-line+Vemurafenib+Cobimetinib.
All 1 trials loaded